Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Medical technology & services

Optibiotix and Knighton's to launch improved version of microbiome-based appetite suppressant Slimbiome

Knighton’s tehcnology will make SlimBiome easier to dissolve and enhancing its ease of use, flavour and mouthfeel

Microbiome pioneer OptiBiotix Health PLC (LON:OPTI) will launch its revised formulation of hunger suppressant product SlimBiome, using a powder technology developed by new partner Knighton’s.

Knighton’s tehcnology will make SlimBiome easier to dissolve and enhances its ease of use, flavour and mouthfeel, said Optibiotix, and will open opportunities in bakeries, snacking, coffee shops and the growing ‘shakes’ market.

WATCH: Massive opportunities for OptiBiotix Health's new and improved SlimBiome

SlimBiome will be sold as an ingredient in white label format and will be highlighted in OptiBiotix's own brand the GoFigure range of shakes and bars.

AIM-listed Optibiotix wants to target the growing 'Health & Wellbeing' lifestyle trend and sees a huge possible range of applications with new flavours and applications such as muesli.

Knighton’s, part of Premier Foods, is one of a number partners that are using Slimbiome to develop products such as cookies, tortillas, breakfast cereals, food toppings, yoghurts and cereal bars.

Eventually, the plan is to ‘white label’ Slimbiome to large retailers, and branded consumer products manufacturers as well as food manufacturers.

READ: OptiBiotix licenses weight-loss technology to Premier Foods offshoot

Slimbiome has been developed from Optibiotix’s work on the human microbiome, the bacteria that inhabits the gut and skin and that is increasingly being recognised as playing a critical part in the way the human body processes food.

Stephen O'Hara, Optibiotix chief executive, said: “We anticipate SlimBiome being the first in a family of products to include: ImmunBiome, WellBiome, OptiBiome and CardioBiome, developed using our advanced microbiome modulating technology platforms.”

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK